uni-leipzig-open-access/json/HS9.0000000000000874

1 line
24 KiB
Plaintext

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:23:14Z","timestamp":1702945394655},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Telomere biology disorders (TBD) result from premature telomere shortening due to pathogenic germline variants in telomere maintenance-associated genes. In adults, TBD are characterized by mono\/oligosymptomatic clinical manifestations (cryptic TBD) contributing to severe underdiagnosis. We present a prospective multi-institutional cohort study where telomere length (TL) screening was performed in either newly diagnosed patients with aplastic anemia (AA) or if TBD was clinically suspected by the treating physician. TL of 262 samples was measured via flow-fluorescence in situ hybridization (FISH). TL was considered suspicious once below the 10th percentile of normal individuals (standard screening) or if below 6.5\u2009kb in patients &gt;40 years (extended screening). In cases with shortened TL, next generation sequencing (NGS) for TBD-associated genes was performed. The patients referred fell into 6 different screening categories: (1) AA\/paroxysmal nocturnal hemoglobinuria, (2) unexplained cytopenia, (3) dyskeratosis congenita, (4) myelodysplastic syndrome\/acute myeloid leukemia, (5) interstitial lung disease, and (6) others. Overall, TL was found to be shortened in 120 patients (n = 86 standard and n = 34 extended screening). In 17 of the 76 (22.4%) standard patients with sufficient material for NGS, a pathogenic\/likely pathogenic TBD-associated gene variant was identified. Variants of uncertain significance were detected in 17 of 76 (22.4%) standard and 6 of 29 (20.7%) extended screened patients. Expectedly, mutations were mainly found in <jats:italic toggle=\"yes\">TERT<\/jats:italic> and <jats:italic toggle=\"yes\">TERC<\/jats:italic>. In conclusion, TL measured by flow-FISH represents a powerful functional in vivo screening for an underlying TBD and should be performed in every newly diagnosed patient with AA as well as other patients with clinical suspicion for an underlying TBD in both children and adults.<\/jats:p>","DOI":"10.1097\/hs9.0000000000000874","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T22:28:55Z","timestamp":1682029735000},"page":"e874","source":"Crossref","is-referenced-by-count":1,"title":["Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria"],"prefix":"10.1002","volume":"7","author":[{"given":"Mareike","family":"Tometten","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Martin","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Robert","family":"Meyer","sequence":"additional","affiliation":[{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"},{"name":"Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany"}]},{"given":"Matthias","family":"Begemann","sequence":"additional","affiliation":[{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"},{"name":"Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany"}]},{"given":"Insa","family":"Halfmeyer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Margherita","family":"Vieri","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Kim","family":"Kricheldorf","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Angela","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[{"name":"Clinic for Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Germany"}]},{"given":"Markus","family":"Radsak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany"}]},{"given":"Philippe","family":"Schafhausen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology, and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}]},{"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Hospital Regensburg, Germany"}]},{"given":"Britta","family":"H\u00f6chsmann","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine and Immunogenetics, University of Ulm, Germany"},{"name":"Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-W\u00fcrttemberg-Hessen and University Hospital Ulm, Germany"}]},{"given":"C.","family":"Matthias Wilk","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Switzerland"}]},{"given":"Claas","family":"Hinze","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology and Immunology, University Hospital Muenster, Germany"}]},{"given":"J\u00f6rg","family":"Chromik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Oncology, Goethe-University, Frankfurt, Germany"}]},{"given":"Michael","family":"Heuser","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}]},{"given":"Michael","family":"Kreuter","sequence":"additional","affiliation":[{"name":"Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany"},{"name":"Academic Center for Pulmonary Medicine, Departments of Pneumology, Mainz University Medical Center, and of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Germany"}]},{"given":"Steffen","family":"Koschmieder","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Jens","family":"Panse","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Susanne","family":"Isfort","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Ingo","family":"Kurth","sequence":"additional","affiliation":[{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"},{"name":"Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany"}]},{"given":"Tim H.","family":"Br\u00fcmmendorf","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]},{"given":"Fabian","family":"Beier","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}]}],"member":"311","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"R1-20231116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.","volume":"11","author":"Martinez","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R2-20231116","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies.","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"key":"R3-20231116","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","article-title":"The biology and management of dyskeratosis congenita and related disorders of telomeres.","volume":"15","author":"Tummala","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"R4-20231116","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases.","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20231116","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s13023-021-02024-8","article-title":"Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry.","volume":"16","author":"Tometten","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R6-20231116","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","article-title":"Short telomeres are a risk factor for idiopathic pulmonary fibrosis.","volume":"105","author":"Alder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-20231116","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/hematology.2022000394","article-title":"Dyskeratosis congenita and telomere biology disorders.","volume":"2022","author":"Savage","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R8-20231116","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"R9-20231116","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.2021011980","article-title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue.","volume":"139","author":"Sharma","year":"2022","journal-title":"Blood"},{"key":"R10-20231116","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood.2021010791","article-title":"Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects.","volume":"139","author":"Kermasson","year":"2022","journal-title":"Blood"},{"key":"R11-20231116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders.","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R12-20231116","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.190.2.157","article-title":"Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood.","volume":"190","author":"Rufer","year":"1999","journal-title":"J Exp Med"},{"key":"R13-20231116","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia.","volume":"97","author":"Brummendorf","year":"2001","journal-title":"Blood"},{"key":"R14-20231116","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.leu.2404339","article-title":"Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover.","volume":"20","author":"Brummendorf","year":"2006","journal-title":"Leukemia"},{"key":"R15-20231116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/asheducation-2010.1.30","article-title":"Telomere biology and telomere diseases: implications for practice and research.","volume":"2010","author":"Young","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R16-20231116","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/nyas.14248","article-title":"Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies.","volume":"1466","author":"Ferreira","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20231116","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2014.114389","article-title":"Telomere length in inherited bone marrow failure syndromes.","volume":"100","author":"Alter","year":"2015","journal-title":"Haematologica"},{"key":"R19-20231116","doi-asserted-by":"crossref","first-page":"E2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting.","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20231116","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"R21-20231116","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/bloodadvances.2020001721","article-title":"Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and\/or pulmonary presentations.","volume":"4","author":"Feurstein","year":"2020","journal-title":"Blood Adv"},{"key":"R22-20231116","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/bloodadvances.2018017772","article-title":"Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.","volume":"2","author":"Bouillon","year":"2018","journal-title":"Blood Adv"},{"key":"R23-20231116","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bjh.16997","article-title":"Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita.","volume":"193","author":"Kirschner","year":"2021","journal-title":"Br J Haematol"},{"key":"R24-20231116","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41375-018-0125-x","article-title":"Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.","volume":"32","author":"Kirschner","year":"2018","journal-title":"Leukemia"},{"key":"R25-20231116","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R26-20231116","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12185-015-1861-6","article-title":"Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan.","volume":"102","author":"Yamaguchi","year":"2015","journal-title":"Int J Hematol"},{"key":"R27-20231116","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations.","volume":"4","author":"Calado","year":"2009","journal-title":"PLoS One"},{"key":"R28-20231116","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis.","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"key":"R29-20231116","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMc1607752","article-title":"Danazol treatment for telomere diseases.","volume":"375","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"key":"R30-20231116","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"key":"R31-20231116","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia.","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"key":"R32-20231116","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.chest.2018.12.011","article-title":"Integrating genomics into management of fibrotic interstitial lung disease.","volume":"155","author":"Adegunsoye","year":"2019","journal-title":"Chest"},{"key":"R33-20231116","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.2016.149476","article-title":"Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.","volume":"101","author":"Keel","year":"2016","journal-title":"Haematologica"},{"key":"R34-20231116","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2003-01-0335","article-title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.","volume":"102","author":"Yamaguchi","year":"2003","journal-title":"Blood"},{"key":"R35-20231116","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"key":"R36-20231116","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0701009104","article-title":"Adult-onset pulmonary fibrosis caused by mutations in telomerase.","volume":"104","author":"Tsakiri","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-20231116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41408-021-00564-7","article-title":"Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths.","volume":"11","author":"Mangaonkar","year":"2021","journal-title":"Blood Cancer J"},{"key":"R38-20231116","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41408-020-00386-z","article-title":"Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes.","volume":"10","author":"Ferrer","year":"2020","journal-title":"Blood Cancer J"},{"key":"R39-20231116","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejhg.2014.170","article-title":"Clinical utility gene card for: Dyskeratosis congenita - update 2015.","volume":"23","author":"Dokal","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R40-20231116","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.mayocp.2018.03.020","article-title":"Short telomere syndromes in clinical practice: bridging bench and bedside.","volume":"93","author":"Mangaonkar","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"R41-20231116","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.mayocp.2019.04.007","article-title":"Clinical applications and utility of a precision medicine approach for patients with unexplained cytopenias.","volume":"94","author":"Mangaonkar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R42-20231116","doi-asserted-by":"crossref","first-page":"e107346","DOI":"10.15252\/embj.2020107346","article-title":"Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.","volume":"40","author":"Kim","year":"2021","journal-title":"EMBO J"},{"key":"R43-20231116","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat Genet"},{"key":"R44-20231116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"R45-20231116","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient.","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"key":"R46-20231116","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"key":"R47-20231116","doi-asserted-by":"crossref","article-title":"Differential diagnosis of bone marrow failure syndromes guided by machine learning.","author":"Gutierrez-Rodrigues","year":"2022 Dec 21","journal-title":"Blood","DOI":"10.1182\/blood.2022017518"},{"key":"R48-20231116","doi-asserted-by":"crossref","first-page":"101282","DOI":"10.1016\/j.beha.2021.101282","article-title":"Treatment of telomeropathies.","volume":"34","author":"Vieri","year":"2021","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HS9.0000000000000874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T18:06:19Z","timestamp":1702922779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HS9.0000000000000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"URL":"http:\/\/dx.doi.org\/10.1097\/hs9.0000000000000874","relation":{},"ISSN":["2572-9241"],"issn-type":[{"value":"2572-9241","type":"electronic"}],"subject":["Hematology"],"published":{"date-parts":[[2023,4,20]]}}}